Hui Zhang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Northwestern University | United States

Hui Zhang is a Professor in the Division of Biostatistics, Department of Preventive Medicine at Northwestern University Feinberg School of Medicine, where he also holds appointments at the Robert H. Lurie Comprehensive Cancer Center, the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and the Center for Epidemiology and Population Health. he serves as Director of the Northwestern Brain Tumor SPORE Biostatistics and Bioinformatics Core and leads the Biostatistics and Data Management Core at the Mesulam Center. With a Ph.D. in Statistics from the University of Rochester, her academic foundation spans pharmacology, neurophysiology, and biology, reflecting her interdisciplinary expertise in biostatistics and biomedical research. His previous experience includes research roles at St. Jude Children’s Research Hospital, where she contributed significantly to clinical and statistical protocol development. Professor Zhang’s work focuses on statistical methodologies for cancer and neurological disease research, data integration, and bioinformatics applications. he is an active member of several professional societies, including the American Statistical Association and the International Chinese Statistical Association. A highly cited researcher, she has accumulated over 11,422 citations, an h-index of 43, and an i10-index of 100, demonstrating her substantial impact and leadership in the fields of biostatistics and medical data science.

Profile: Google Scholar

Featured Publications

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361(14), 1329–1338.

Gunzler, D., Chen, T., Wu, P., & Zhang, H. (2013). Introduction to mediation analysis with structural equation modeling. Shanghai Archives of Psychiatry, 25(6), 390–394.

Wan, T., Jun, H. U., Pan, W. U., & Hua, H. E. (2015). Kappa coefficient: A popular measure of rater agreement. Shanghai Archives of Psychiatry, 27(1), 62–67.

Pu, J., Wang, S., Yin, Y., Zhang, G., Carter, R. A., Wang, J., Xu, G., Sun, H., Wang, M., et al. (2015). Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences, 112(2), 548–553.

Guy, C. S., Vignali, K. M., Temirov, J., Bettini, M. L., Overacre, A. E., Smeltzer, M., et al. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology, 14(3), 262–270.

Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., Hu, S., Zhai, X., Liang, C., Ju, X., Jiang, H., et al. (2020). Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncology, 6(3), 358–366.

Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., et al. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: A phase 1 trial. The Lancet Oncology, 24(5), 509–522.

William Blumentals | Clinical Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Dr. William Blumentals | Clinical Neuroscience | Excellence in Research Award

Dr. William Blumentals | Sanofi | United States

Dr. William A. Blumentals is an accomplished epidemiologist and pharmaceutical executive recognized for his leadership in pharmacoepidemiology, real-world evidence generation, and global health outcomes research. He serves as Associate Vice President and Head of Specialty Care Pharmacoepidemiology at Sanofi in Cambridge, Massachusetts, where he oversees a multinational team of epidemiologists across the United States and Europe, driving innovation in inflammation, immunology, oncology, and rare disease research. With a Ph.D. in Epidemiology from the University of South Florida, along with advanced degrees in Statistics, Epidemiology, and Biology, Dr. Blumentals has held senior positions at leading organizations including Shire Pharmaceuticals, Shionogi Inc., and Hoffmann-La Roche. His expertise spans strategic development of large-scale observational studies, organizational leadership, and cross-functional collaboration to optimize evidence-based decision-making in healthcare. As a thought leader in real-world evidence and outcomes research, he has contributed significantly to advancing global epidemiological practices. Dr. Blumentals has authored 36 scientific documents, accumulated 1,594 citations from 1,463 documents, and holds an h-index of 23, reflecting his strong scientific influence and impact in epidemiology and pharmaceutical research.

Profile: Scopus

Featured Publications

Multiple sclerosis and the association with inflammatory bowel disease: Results from a retrospective cohort study. (2025). Multiple Sclerosis and Related Disorders.


Cytokine release syndrome risk model with T-cell engaging therapies. (2025). Cytotherapy.


Evaluating the accuracy of responses by large language models for information on disease epidemiology. (2025). Pharmacoepidemiology and Drug Safety.

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Dr. Eleni Tsakiri |  National and Kapodistrian University of Athens Medical School | Greece

Dr. Eleni Tsakiri is a distinguished Molecular Biologist whose research centers on the molecular mechanisms of aging, proteostasis, and neurodegeneration. She earned her Ph.D. in Biology from the National and Kapodistrian University of Athens (NKUA) with a thesis on proteome homeostasis and its alterations during aging, following her M.Sc. in Cell Biology and Biophysics and a B.Sc. in Molecular Biology and Genetics. Dr. Tsakiri has held multiple postdoctoral positions at leading Greek institutions, including the Medical School of NKUA and the Biomedical Research Center “Alexander Fleming,” where she contributed to projects on proteasome regulation, Tau aggregation, and ribosome-mediated cell competition. Currently, she serves as a Postdoctoral Researcher at the Laboratory of Physiology, NKUA, focusing on neurodegeneration and aging under an ERC-funded project. Her research is supported by competitive grants such as the Hellenic Foundation for Research and Innovation (HFRI). She has supervised undergraduate, master’s, and doctoral students and actively collaborates with prominent researchers in Greece and abroad. Dr. Tsakiri’s contributions are reflected in her 24 published documents, 730 citations, and an h-index of 15, highlighting her impact in molecular biology and aging research.

Profiles: Scopus | Google Scholar | Research Gate | LInked In

Featured Publications

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Terpos, E., Dimopoulos, M. A., & others. (2013). Proteasome dysfunction in Drosophila signals to an Nrf2‐dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell, 12(5), 802–813.

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Gorgoulis, V. G., Bohmann, D., & others. (2013). Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress. The FASEB Journal, 27(6), 2407–2419.

  • Tsakiri, E. N., & Trougakos, I. P. (2015). The amazing ubiquitin-proteasome system: Structural components and implication in aging. International Review of Cell and Molecular Biology, 314, 171–237.

  • Tsakiri, E. N., Iliaki, K. K., Höhn, A., Grimm, S., Papassideri, I. S., & Grune, T. (2013). Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Free Radical Biology and Medicine, 65, 1155–1163.

  • Tsakiri, E. N., Gumeni, S., Iliaki, K. K., Benaki, D., Vougas, K., Sykiotis, G. P., et al. (2019). Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation. Aging Cell, 18(1), e12845.

Nasar Ata | Neurology | Best Researcher Award

Published on by Neuroscientists

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Amrita Vishwa Vidyapeetham | India

Ms. Priyadharshini Veeralakshmanan is a dedicated PhD scholar at Amrita Vishwa Vidyapeetham, specializing in Medical Oncology with a focus on Breast Cancer Immunology and the immunosuppressive tumour microenvironment (TME), particularly in Triple-Negative Breast Cancer (TNBC). Her doctoral research involves a Phase 2/3 open-label pilot clinical trial to evaluate neoadjuvant metronomic chemotherapy for modulating the TME and enhancing chemo- and immunotherapy responses, quantifying immunosuppressive cells and tumour-infiltrating lymphocytes from blood and tumour tissue. She holds an M.Sc. in Physician Assistant (Medical Oncology) and a B.Sc. in Physician Assistant (General Medicine), with extensive clinical training in oncology, hematology, surgical oncology, radiation oncology, and palliative care. Priyadharshini has strong expertise in flow cytometry, cell culture, in vitro drug testing, cytotoxicity assays, systematic reviews, meta-analysis, and clinical trial design, using advanced analytical tools such as FlowJo, SPSS, and GraphPad Prism. She has authored several publications, with an h-index of 3, over 7 documents, and more than 50 citations. A member of ESMO, ASCO, and I-OSI, she is committed to advancing cancer research, translating innovative findings into clinical practice to improve patient outcomes globally.

Profiles: Orcid | Linked In

Featured publications

Veeralakshmanan, P., Jose, W. M., Udayakumaran, S., Bindhu, M. R., Dutta, D., Rajesh, K., Kavalagunta, S., Bhaskaran, R., Haridas, N. K., Rakesh, M. P., et al. (2025). Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study. Malignancy Spectrum.

Surendran, H. P., Sah, S. K., Veeralakshmanan, P., Nair, P., Ashok, H. P., Unnikrishnan, M. K., Kalavagunta, S., Sasidharan, A., Chandran, D., Poornachary, N. M., et al. (2025). Efficacy of hippocampal avoidance whole brain radiotherapy to preserve the cognitive functions among brain metastasis patients: Systematic review and meta-analysis. Neurology India, 73(5), 715–725.

Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.

Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Dr. Jaleel Miyan | The University of Manchester | United Kingdom

Dr. Jaleel Ahmad Miyan is a distinguished British neuroscientist and Senior Lecturer at the Faculty of Biology, Medicine & Health, Division of Neuroscience, University of Manchester, with a long-standing career dedicated to understanding cerebrospinal fluid (CSF) physiology and its role in neurological disorders. As President of the Society for Research into Hydrocephalus & Spina Bifida and a Fellow of both the Higher Education Academy and the Royal Society of Biology, he is recognized internationally for his expertise in cerebral folate metabolism and hydrocephalus research. His principal work focuses on fetal-onset and neonatal hydrocephalus, aiming to develop a non-invasive, non-surgical treatment to address global disparities in care. Miyan has supervised numerous PhD and Masters students, postdoctoral researchers, and technicians, fostering research excellence. He has published over 120 peer-reviewed research papers and reviews, with an h-index of 34, and his work has garnered substantial citations, reflecting his impact in neuroscience. He has served on editorial boards, contributed to major research projects, and secured significant funding for studies on folate metabolism in neurological conditions. Miyan’s scholarship is accessible through his ResearchGate, Orcid, and Google Scholar profiles, showcasing his profound contributions to advancing neuroscience and improving treatments for devastating neurological conditions.

Profiles : Google Scholar | Orcid | Research Gate

Featured Publications

Downing, J. E. G., & Miyan, J. A. (2000). Neural immunoregulation: Emerging roles for nerves in immune homeostasis and disease. Immunology Today, 21(6), 281–289.

Assas, B. M., Pennock, J. I., & Miyan, J. A. (2014). Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Frontiers in Neuroscience, 8, 23.

Miyan, J. A., Nabiyouni, M., & Zendah, M. (2003). Development of the brain: A vital role for cerebrospinal fluid. Canadian Journal of Physiology and Pharmacology, 81(4), 317–328.

Gazi, E., Dwyer, J., Lockyer, N. P., Miyan, J., Gardner, P., Hart, C., & Brown, M., et al. (2005). Fixation protocols for subcellular imaging by synchrotron‐based Fourier transform infrared microspectroscopy. Biopolymers: Original Research on Biomolecules, 77(1), 18–30.

Mashayekhi, F., Draper, C. E., Bannister, C. M., Pourghasem, M., & Miyan, J. A., et al. (2002). Deficient cortical development in the hydrocephalic Texas (H‐Tx) rat: A role for CSF. Brain, 125(8), 1859–1874.

Owen‐Lynch, P. J., Draper, C. E., Mashayekhi, F., Bannister, C. M., & Miyan, J. A. (2003). Defective cell cycle control underlies abnormal cortical development in the hydrocephalic Texas rat. Brain, 126(3), 623–631.

Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Mrs. Rezvan Ghafarzadegan | Tarbiat Modares University | Iran

Rezvan Ghafarzadegan is a distinguished nursing scholar specializing in Medical-Surgical Education, holding an M.Sc. in Nursing from Tehran University of Medical Sciences and a B.Sc. in Nursing from Arak University of Medical Sciences, both completed with exceptional academic honors and outstanding GPAs. She is currently a Ph.D. candidate in Nursing at Tarbiat Modares University, demonstrating a strong commitment to advancing nursing education and clinical practice. Rezvan has extensive teaching experience, serving as an instructor for Medical-Surgical Nursing, Emergency Medicine, Internal Diseases, Medical Ethics, Pathophysiology, Orthopedic Surgical Technology, and Introduction to Surgical Technology. She also has broad clinical instruction expertise in Emergency, Internal Medicine (Gastroenterology & Endocrinology), Orthopedics, Neurosurgery, and General Surgery, along with operating room education. Her scholarly contributions include 9 published documents that have collectively earned 31 citations, reflecting her growing impact in the field, and she holds an h-index of 3. Recognized throughout her academic journey as an exceptional talent student, Rezvan combines clinical expertise with a deep dedication to research, striving to improve nursing education and patient care through both her teaching and scientific endeavors.

Profiles: Scopus | Orcid | Research gate

Featured Publications

Zarei, M., Norouzi, N., Teymoori, E., & Ghafarzadegan, R. (2025). Covering sterile instrument tables to prevent airborne bacterial contamination and surgical wound infections: A narrative review of operating room nursing practices. Perioperative Care and Operating Room Management, 100495.

Ghafarzadegan, R., Zarei, M., Norouzi, N., Mirbagher Ajorpaz, N., Lotfi, S. M., Rasooli Manesh, S. M., Akbari, H., & Abedi, A. (2025). Efficacy of an Iranian herbal medicine formula for postoperative constipation in trauma patients with hip and lower limb fractures: A triple-blind, placebo-controlled randomized clinical trial. International Journal of Orthopaedic and Trauma Nursing, 101163.

Javaheri, J., Asgari, M., & Ghafarzadegan, R. (2023). The effect of Nigella sativa powder on blood sugar and lipid profiles in type 2 diabetic patients. Jundishapur Journal of Natural Pharmaceutical Products, e135757.

Sang Yun Seok | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Sang Yun Seok | Clinical Neuroscience | Best Researcher Award 

Prof. Sang Yun Seok,  Busan Bumin Hospital, South Korea.

Dr. Sangyun Seok is a highly accomplished spine surgeon and medical academic whose career spans clinical excellence, international training, and impactful research. He completed his medical education and master’s degree at Dong-A University, followed by intensive clinical training and military service. His professional career includes esteemed positions at Asan Medical Center, Eulji Medical Center, and fellowships in the USA, UK, and Japan, culminating in his current role at Busan Bumin Hospital. Dr. Seok’s primary research focus lies in cervical spine surgery and minimally invasive techniques, with numerous publications in top-tier international journals. His clinical expertise, global collaborations, and forward-looking vision continue to influence the field of spinal surgery.

Profile

Orcid

⭐ Strengths for the Award

  • Focused Research Expertise: His specialized focus on cervical spine surgery and minimally invasive spine techniques addresses high-impact areas in clinical orthopedics and neurosurgery, benefiting both patients and the broader medical community.

  • Robust Publication Record: Dr. Seok has published in top-tier journals including Neurospine, Clinical Spine Surgery, Global Spine Journal, and J Neurosurg Spine, contributing to both practical advancements and theoretical insights in spine surgery.

⚠️ Areas for Improvement

  • Grant Acquisition and Leadership Roles: There is limited information on leading major funded research projects or international consortia. Taking lead investigator roles in large-scale studies or securing competitive research grants would significantly bolster his profile.

  • Innovation and Patents: Future work could include intellectual property contributions, such as device development, patents, or clinical guidelines, to complement his strong publication base.

🎓 Early Academic Pursuits

Dr. Sangyun Seok embarked on his medical journey at Dong-A University College of Medicine in Busan, Korea, where he earned his Bachelor’s degree in Medicine between 2006 and 2012. His passion for advancing medical knowledge led him to pursue a Master’s degree in Medicine from the same institution during 2014–2016, laying a solid academic foundation in clinical and surgical sciences. His formative years were marked by diligence, academic excellence, and a clear focus on the musculoskeletal and spinal health domains.

🏥 Professional Endeavors

Following his academic achievements, Dr. Seok underwent rigorous clinical training at Dong-A University Hospital from 2012 to 2017, where he honed his clinical and surgical skills. After serving his nation through the Korean military service from 2017 to 2020, he returned to the healthcare field with renewed dedication. His professional career advanced rapidly with appointments at Asan Medical Center in Seoul, followed by a tenure as Assistant Professor at Eulji Medical Center in Daejeon (2021–2025). Dr. Seok’s career reflects a blend of clinical service, academic leadership, and global medical engagement, including fellowships in the USA, UK, and Japan. As of 2025, he continues his professional journey at Busan Bumin Hospital, further strengthening Korea’s spine surgery community.

🔬 Contributions and Research Focus

Dr. Seok’s research contributions are deeply rooted in the field of spine surgery, with a sharp focus on the cervical spine and minimally invasive surgical techniques. His academic output reflects a commitment to improving surgical outcomes and patient recovery. Among his impactful works are studies on vertebral osteotomy for cervical myelopathy, postoperative delirium after knee arthroplasty, and minimally invasive approaches in complex cervical procedures. His research has been published in reputable journals such as Neurospine, Clinical Spine Surgery, Global Spine Journal, and Journal of Neurosurgery: Spine, underlining his authority and innovation in spine surgery.

Publication


Title: Analysis of Early Post-Radiation Surgical Management of Metastatic Spinal Tumors
Author: SANGYUN SEOK, Jae Hwan Cho, Hyung Rae Lee, Jae Woo Park, Jin Hoon Park, Dong-Ho Lee, Chang Ju Hwang, Sehan Park
Year: 2025


Title: Mechanical Stability and Clinical Outcomes Following Posterior Cervical Fusion Surgery Using C3-6 Lateral Mass Screw Fixation: En Bloc Versus Regional Screw Fixation
Author: Dong-Ho Lee, SANGYUN SEOK, Woon Sang Lee, Hyung Rae Lee, Sehan Park, Chang Ju Hwang, Jae Hwan Cho
Year: 2025

🏁 Conclusion

Dr. Sangyun Seok is highly deserving of the Best Researcher Award. His trajectory is marked by deep scientific curiosity, technical mastery, and global vision. His work has already contributed meaningfully to advancing spinal surgery, and with continued research leadership, he is poised to make even greater contributions in the years ahead. Recognizing him with this award would not only honor his current accomplishments but also inspire future breakthroughs in spine medicine and academic surgery.